实用医学杂志 ›› 2026, Vol. 42 ›› Issue (7): 1126-1133.doi: 10.3969/j.issn.1006-5725.2026.07.002
• 指南·共识·解读 • 上一篇
收稿日期:2025-12-29
修回日期:2025-01-14
接受日期:2025-01-16
出版日期:2026-04-10
发布日期:2026-04-13
通讯作者:
吴于青,张齐龙,陈中书,廖永美
基金资助:
Received:2025-12-29
Revised:2025-01-14
Accepted:2025-01-16
Online:2026-04-10
Published:2026-04-13
摘要:
妊娠合并结核病是指在妊娠期间罹患结核病或育龄期女性在结核病未愈时出现妊娠。妊娠合并结核病在临床上并不少见,根据世界卫生组织(WHO)统计,每年约有20万孕妇罹患活动性结核病,其中大多数来自于高负担国家。随着体外受精-胚胎移植术(in vitro fertilization and embryo transfer,IVF-ET)的广泛开展,妊娠合并播散性结核病患者明显增加。近年来,多项研究证实,妊娠期结核病早期诊断和规范化治疗能够明显改善母婴结局,而延误治疗则可能导致血行播散性肺结核或结核性脑膜炎等重症结核病。由于涉及伦理问题,难以开展大样本随机对照试验,缺少相应的循证医学数据。为进一步规范妊娠合并结核病的临床诊治,国家感染性疾病临床医学研究中心江西分中心,中国防痨协会临床试验专业委员会、江西省医学会结核病分会,南昌医学院难治性结核病诊疗创新团队等组织专家结合国内外最新研究进展,讨论制定本共识,旨在为临床实践提供系统指导。
中图分类号:
. 妊娠合并结核病的筛查、诊断与治疗专家共识[J]. 实用医学杂志, 2026, 42(7): 1126-1133.
表1
GRADE证据等级和推荐强度分级"
| 级别 | 详细说明 |
|---|---|
| 证据级别 | |
| 高质量(A) | 研究数据与真实效应值高度吻合,后续验证性研究难以动摇现有结论的可靠性 |
| 中等质量(B) | 现有研究提示效应值具备合理可信度,但存在一定误差可能。真实效应存在偏离当前估测值的潜在风险,补充研究可能对结论确定性产生显著影响 |
| 低质量(C) | 效应评估存在较大不确定性区间,真实效应与当前结论存在实质性差异的可能性较高。亟需更多研究验证,现有结论可能面临实质性修正 |
| 推荐强度 | |
| 强推荐(1) | 基于高质量证据的综合判断,干预措施在风险收益比、成本效益评估和患者预后改善方面具有显著优势。推荐意见适用于绝大多数临床情境 |
| 弱推荐(2) | 证据基础存在异质性或局限性,临床决策需权衡多方因素。可能涉及以下情况:疗效证据不确定、风险收益比存在争议、患者偏好差异显著,或需要结合具体医疗资源配置进行个体化决策 |
| [1] |
SUGARMAN J, COLVIN C, MORAN A C, et al. Tuberculosis in pregnancy: An estimate of the global burden of disease[J]. Lancet Glob Health, 2014, 2(12): e710-e716. doi: 10.1016/S2214-109X(14)70330-4 .
doi: 10.1016/S2214-109X(14)70330-4 |
| [2] |
JONSSON J, KÜHLMANN-BERENZON S, BERGGREN I, et al. Increased risk of active tuberculosis during pregnancy and postpartum: A register-based cohort study in Sweden[J]. Eur Respir J, 2020, 55(3): 1901886. doi: 10.1183/13993003. 01886-2019 .
doi: 10.1183/13993003. 01886-2019 |
| [3] |
SAHA A, ESCUDUERO J, LAYOUNI T, et al. Mycobacterium tuberculosis-Specific T-Cell Responses Are Impaired During Late Pregnancy With Elevated Biomarkers of Tuberculosis Risk Postpartum[J]. J Infect Dis, 2022, 225(9): 1663-1674. doi: 10.1093/infdis/jiab614 .
doi: 10.1093/infdis/jiab614 |
| [4] |
WALLES J, WINQVIST N, HANSSON S R, et al. Pregnancy Outcomes in Women Screened for Tuberculosis Infection in Swedish Antenatal Care[J]. Clin Infect Dis, 2024, 78(1): 125-132. doi: 10.1093/cid/ciad465 .
doi: 10.1093/cid/ciad465 |
| [5] |
ZENNER D, KRUIJSHAAR M E, ANDREWS N, et al. Risk of tuberculosis in pregnancy: A national, primary care-based cohort and self-controlled case series study[J]. Am J Respir Crit Care Med, 2011, 185 (7): 779-784. doi: 10.1164/rccm.201106-1083OC .
doi: 10.1164/rccm.201106-1083OC |
| [6] |
STARSHINOVA A, CHURILOV L P, KUDRYAVTSEV I, et al. Immune-neuroendocrine reactivity and features of tuberculosis in pregnancy[J]. Front Med (Lausanne), 2025, 12: 1503402. doi: 10.3389/fmed.2025.1503402 .
doi: 10.3389/fmed.2025.1503402 |
| [7] |
MATHAD J S, SAVIC R, BRITTO P, et al. Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women[J]. Clin Infect Dis,2022,74 (9): 1604-1613. doi: 10.1093/cid/ciab665 .
doi: 10.1093/cid/ciab665 |
| [8] |
SU Y F, KONG X X, CHEN Z P, et al. Adverse pregnancy outcomes and complications of tuberculosis in pregnant women[J]. Front Cell Infect Microbiol, 2025, 15: 1550430. doi:10.3389/fcimb.2025.1550430 .
doi: 10.3389/fcimb.2025.1550430 |
| [9] |
SOBHY S, BABIKER Z, ZAMORA J, et al. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: A systematic review and meta-analysis[J]. BJOG, 2016, 124(5): 727-733. doi: 10.1111/1471-0528.14408 .
doi: 10.1111/1471-0528.14408 |
| [10] |
ALENE K A, MURRAY M B, WATER B J, et al. Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis[J]. JAMA Netw Open, 2022, 5(6): e2216527. doi: 10.1001/jamanetworkopen.2022.16527 .
doi: 10.1001/jamanetworkopen.2022.16527 |
| [11] |
Notes from the Field: Undiagnosed Tuberculosis During Pregnancy Resulting in a Neonatal Death-United States, 2021[J]. Pediatr Infect Dis J, 2024. doi: 10.1097/INF.0000000000004324 .
doi: 10.1097/INF.0000000000004324 |
| [12] |
ZOU J, LI J, WANG X, et al. Case Report Series and Mini Review on Tuberculosis in in vitro Fertilization and Embryo Transfer Pregnancies: A Call for Vigilant Monitoring and Early Intervention[J]. Respiration, 2025, 104(10): 781-790. doi: 10.1159/000546340 .
doi: 10.1159/000546340 |
| [13] |
PANDEY N. Pregnancy with Tuberculosis: What’s New![J]. JoARM, 2021, 8(4): 26-31. doi: 10.24321/2349.7181.202120 .
doi: 10.24321/2349.7181.202120 |
| [14] |
NORDHOLM A C, SUPPLI C H, NORMAN A, et al. Pregnancy and post-partum tuberculosis: A nationwide register-based case-control study, Denmark, 1990 to 2018[J]. Euro Surveill, 2022, 27(12): 2100949. doi:10.2807/1560-7917.ES.2022.27.12. 2100949 .
doi: 10.2807/1560-7917.ES.2022.27.12. 2100949 |
| [15] |
ORAZULIKE N, SHARMA J B, SHARMA S, et al. Tuberculosis (TB) in pregnancy-A review[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 259: 167-177. doi: 10.1016/j.ejogrb.2021.02. 016 .
doi: 10.1016/j.ejogrb.2021.02. 016 |
| [16] |
BHOSALE R, ALEXANDER M, DESHPANDE P, et al. Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India[J]. Int J Infect Dis, 2021, 112: 205-211. doi: 10.1016/j.ijid.2021.09.010 .
doi: 10.1016/j.ijid.2021.09.010 |
| [17] |
TESFAYE F, WALLES J, STUREGÅRD E, et al. Longitudinal Mycobacterium tuberculosis-Specific Interferon Gamma Responses in Ethiopian HIV-Negative Women during Pregnancy and Postpartum[J]. J Clin Microbiol, 2021, 59 (10): e0086821. doi:10.1128/JCM.00868-21 .
doi: 10.1128/JCM.00868-21 |
| [18] |
WEINBERG A, AARON L, MONTEPIEDRA G, et al. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV[J]. Clin Infect Dis, 2021, 73(9): e3555-e3562. doi: 10.1093/cid/ciaa1083 .
doi: 10.1093/cid/ciaa1083 |
| [19] |
MATHAD J S, BHOSALE R, SANGAR V, et al. Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting[J]. PLoS One, 2014, 9(3): e92308. doi: 10.1371/journal.pone.0092308 .
doi: 10.1371/journal.pone.0092308 |
| [20] |
陈燕琴, 高微微. 妊娠合并结核病的治疗进展[J].中华结核和呼吸杂志, 2021, 44(5): 413-416. doi:10.3760/cma.j.cn112147-20210219-00110 .
doi: 10.3760/cma.j.cn112147-20210219-00110 |
| [21] |
HUI S Y, LAO T T. Tuberculosis in pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2022, 85 (Pt A): 34-44. doi: 10.1016/j.bpobgyn.2022.07.006 .
doi: 10.1016/j.bpobgyn.2022.07.006 |
| [22] | CENTERS FOR DISEASE CONTROL AND PREVENTION. Latent tuberculosis infection: A guide for primary health care providers[EB/OL]. (2024-04-02)[2025-12-20]. . |
| [23] |
TESFAYE F, STUREGÅRD E, WALLES J, et al. Dynamics of Mycobacterium tuberculosis-Specific and Nonspecific Immune Responses in Women with Tuberculosis Infection during Pregnancy[J]. Microbiol Spectr, 2022, 10(5): e0117822. doi: 10.1128/spectrum.01178-22 .
doi: 10.1128/spectrum.01178-22 |
| [24] |
WATER B J, BROOKS M B, HUANG C C, et al. Tuberculosis clinical presentation and treatment outcomes in pregnancy: A prospective cohort study[J]. BMC Infect Dis, 2020, 20(1): 686. doi: 10.1186/s12879-020-05416-6 .
doi: 10.1186/s12879-020-05416-6 |
| [25] |
Committee Opinion No.723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation: Correction[J]. Obstet Gynecol, 2018, 132(3): 786. doi: 10.1097/AOG.0000000000002858 .
doi: 10.1097/AOG.0000000000002858 |
| [26] |
WORLD HEALTH ORGANIZATION. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis: rapid diagnostics for tuberculosis detection[EB/OL]. Geneva: World Health Organization, (2024-03-20) [2025-12-20]. . doi:10.2471/b09341
doi: 10.2471/b09341 |
| [27] |
LOVEDAY M, HUGHES J, MCHUNU N, et al. Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa[J]. Clin Infect Dis, 2025: ciaf593. doi: 10.1093/cid/ciaf593 .
doi: 10.1093/cid/ciaf593 |
| [28] | Health Queensland. Management of tuberculosis in pregnant women and newborn infants: Guideline, Version 3.3[EB/OL]. (2021-11) [2026-01-10]. . |
| [29] |
HUGHES J A, PINILLA M, BROOKS K M, et al. Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s[J]. Clin Pharmacokinet, 2025, 64(4): 619-630. doi: 10.1007/s40262-025-01498-0 .
doi: 10.1007/s40262-025-01498-0 |
| [30] |
LOTIA F I, LACHENAL N, ADENOV M M, et al. Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs[J]. Clin Infect Dis, 2024, 78. doi: 10.1093/cid/ciad445 .
doi: 10.1093/cid/ciad445 |
| [31] |
CROCKER B T, LACHENAL N, NARASIMOOLOO C, et al. Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL[J]. Clin Infect Dis, 2024, 79(2): 569-570. doi: 10.1093/cid/ciad767 .
doi: 10.1093/cid/ciad767 |
| [32] |
WORLD HEALTH ORGANIZATION. Key updates to the treatment of drug-resistant tuberculosis: Rapid communication, June 2024[EB/OL]. Geneva: World Health Organization, (2024-08-19) [2025-12-31]. . doi:10.2471/b09123
doi: 10.2471/b09123 |
| [33] |
VAN S M, BEKKER A, DECLOEDT E, et al. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: Results from IMPAACT P1026s[J]. Antimicrob Agents Chemother, 2023, 67(11): e0073723. doi: 10.1128/aac.00737-23 .
doi: 10.1128/aac.00737-23 |
| [34] |
GAI X, CHI H, CAO W, et al. Acute miliary tuberculosis in pregnancy after in vitro fertilization and embryo transfer: A report of seven cases[J]. BMC Infect Dis, 2021, 21(1): 913. doi: 10.1186/s12879-021-06564-z .
doi: 10.1186/s12879-021-06564-z |
| [35] |
GAI X Y, CHI H B, ZENG L, et al. Impact of Positive Interferon-Gamma Release Assay on IVF-ET Pregnancy Outcomes in Infertile Patients With Untreated Prior Tuberculosis: A Prospective Cohort Study[J]. Front Med (Lausanne), 2021, 8: 749410. doi:10.3389/fmed.2021.749410 .
doi: 10.3389/fmed.2021.749410 |
| [36] |
LI H, GAO M, DONG X, et al. Analysis of pregnancy outcomes and associated risk factors for tuberculosis recurrence during pregnancy in patients with prior tuberculosis undergoing IVF-ET[J]. BMC Pregnancy Childbirth, 2025, 25(1): 183. doi: 10.1186/s12884-025-07285-w .
doi: 10.1186/s12884-025-07285-w |
| [37] |
JIRGE P R, CHOUGULE S M, KENI A, et al. Latent genital tuberculosis adversely affects the ovarian reserve in infertile women[J]. Hum Reprod, 2018, 33(7): 1262-1269. doi: 10.1093/humrep/dey117 .
doi: 10.1093/humrep/dey117 |
| [38] |
SHARMA J B, SHARMA S, SHARMA E, et al. Immune disturbances in female genital tuberculosis and latent genital tuberculosis[J]. Am J Reprod Immunol., 2022, 89 (2): e13632. doi: 10.1111/aji.13632 .
doi: 10.1111/aji.13632 |
| [39] |
吴惠忠, 胡锦兴. 结核病传播研究进展[J]. 实用医学杂志, 2023, 39(19): 2424-2427. doi: 10.3969/j.issn.1006-5725. 2023.19.002 .
doi: 10.3969/j.issn.1006-5725. 2023.19.002 |
| [40] |
JANA N, ARORA N, TRIPATHI S K. Re: Multidrug-resistant tuberculosis during pregnancy and adverse birth outcomes: A systematic review and meta-analysis: Practice-embedded research to address knowledge gaps in multidrug-resistant tuberculosis in pregnancy[J]. BJOG, 2021, 128(13): 2209-2210. doi: 10.1111/1471-0528.16873 .
doi: 10.1111/1471-0528.16873 |
| [1] | . 肺结核主动筛查循证指南[J]. 实用医学杂志, 2026, 42(7): 1105-1125. |
| [2] | 李凯,王兴,曾治军,程序,石波. 经直肠实时组织弹性成像联合MRI在前列腺良恶性病变诊断中的应用及影像学特点[J]. 实用医学杂志, 2026, 42(6): 1070-1077. |
| [3] | 王江怀,张晓荷,陈雯. 耐多药/利福平耐药结核病患者心理健康状况与治疗依从性的关联[J]. 实用医学杂志, 2026, 42(6): 937-943. |
| [4] | 张瓅方,张晖,李凯,卞华. 食管鳞癌免疫微环境异质性及免疫治疗联合策略[J]. 实用医学杂志, 2026, 42(6): 944-951. |
| [5] | 尹茉莉,罗文彬,罗思宇,林夕塞,陈三强,孙美艳. 具有pH响应性载硼替佐米纳米粒靶向治疗多发性骨髓瘤[J]. 实用医学杂志, 2026, 42(6): 959-968. |
| [6] | 梁苏东,黄子强,林建中. 瑞维鲁胺联合雄激素剥夺治疗转移性激素敏感性前列腺癌患者近远期疗效及对FPSAR、ProGRP表达的影响[J]. 实用医学杂志, 2026, 42(6): 969-980. |
| [7] | 倪晨,王少开,宋宇,陶晨洁,蒋健,陈志鹏,朱惠平. 信迪利单抗联合化疗转化治疗不可切除局部晚期食管鳞癌的疗效与预后分析[J]. 实用医学杂志, 2026, 42(6): 981-990. |
| [8] | 林欢,李洪胜,黄梅,张国淳,王能,黄冠群,许娟,邹青峰,石兴源,何文广,李锋,蔡延庆,黄晓平,黄琼刁,杨泽娟,罗润妹,张洁文,唐毅,许朝亮,高红飞,陈伟财,胡灏,姚勇生,黄楚,黄杰文,黄毅超,雷叶雁,罗明,吴哲,袁南贵,林泳婷. 乳腺癌围化疗期中西医结合冰冻治疗管理专家共识[J]. 实用医学杂志, 2026, 42(5): 723-733. |
| [9] | 王正刚,熊慧,何霆,刘晓静,叶艳华. 血清MT、IGFBP3水平对年龄相关性白内障的诊断及预后评估价值[J]. 实用医学杂志, 2026, 42(5): 831-837. |
| [10] | 陈贵雄,刘鑫,李范强,蔡丹娴,郑正涛,甘晓鹏,刘巍,王康玲. 不同踝关节体位下冲击波治疗卒中后小腿三头肌痉挛的随机对照研究[J]. 实用医学杂志, 2026, 42(5): 838-845. |
| [11] | 邓万溪,阿地力江·阿不都沙拉木,胡瀛宇,梁敏莉,陈海云,刘军. 清宫正骨肩关节手法对肩袖修补术后患者摸背活动受限的疗效观察[J]. 实用医学杂志, 2026, 42(3): 371-378. |
| [12] | 范莉莉,李红敏,周刊,徐博. 脂肪肝指数在代谢功能障碍相关脂肪性肝病筛查中的诊断效能分析[J]. 实用医学杂志, 2026, 42(3): 416-424. |
| [13] | 薛廷政,梁凤霞,黄柳杨,王雅媛,宋燕娟. 脂肪中SIRT1调控肥胖和胰岛素抵抗的研究进展及靶向治疗策略[J]. 实用医学杂志, 2026, 42(3): 455-462. |
| [14] | 安建虹,宋美慧,黄长文. 胰腺腺鳞癌研究进展:组织学特征、分子机制与治疗前景[J]. 实用医学杂志, 2026, 42(2): 169-175. |
| [15] | 刘逢仁,李鹏程,张文,李丰. 血清IL-7、LDH/ALB、sCD14-ST在慢性阻塞性肺疾病合并肺部感染诊断和病情评估中的应用[J]. 实用医学杂志, 2026, 42(2): 236-248. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||

